What You Should Know
- Cancer AI pioneer Hurone AI has entered into a strategic know-how agreement to license Mayo Clinic’s HOUSES (HOUsing-based index of Socioeconomic Status) technology.
- The collaboration natively embeds Mayo Clinic’s validated social determinants of health (SDoH) tool directly into Hurone’s governed cancer navigation ecosystem.
- The proprietary HOUSES metric calculates an individual’s socioeconomic standing based exclusively on housing features and has been clinically validated to predict more than 70 distinct health outcomes.
- By combining real-time clinical monitoring with social intelligence, the infrastructure automatically flags oncology patients facing severe non-biological vulnerabilities, including transportation barriers, financial toxicity, and food insecurity.
- Hurone AI’s flagship platform, Hurona, is natively integrated into the Epic EHR, automating complex oncology workflows across prominent academic medical centers to enhance treatment adherence.
Activating Social Intelligence via Individual-Level Housing Analytics
The core methodology driving Hurone AI moves past generic zip-code averages to enforce a highly localized model of social risk stratification. The licensed HOUSES index leverages specific housing characteristics to formulate a precise, individual-level measurement of socioeconomic status. Backed by an extensive library of clinical validation, the HOUSES system has been proven to predict more than 70 distinct health outcomes, providing a robust statistical tool for clinical risk modeling.
Operating through Hurone’s flagship product, Hurona, the platform acts as an automated clinical and social co-pilot that guides patients through the complex continuum from initial diagnosis through long-term survivorship:
- Real-Time Patient Companion: The platform interacts continuously with the patient, delivering structured treatment education, 24/7 symptom management guidance, and logistics coordination.
- Social Risk Stratification: By computing the HOUSES index internally, the AI dynamically highlights individuals at elevated risk for treatment non-adherence due to underlying financial or environmental precarity.
- Proactive Resource Matching: Rather than just logging the deficit, the system generates automated alerts to bridge the gap—instantly connecting the patient with localized financial assistance programs, non-emergency medical transportation services, or dedicated nutrition access networks.
“Cancer outcomes are determined not only by biology and treatment, but by the social and economic circumstances patients navigate every day,” stated Dr. Kingsley I. Ndoh, Founder and CEO of Hurone AI. “By collaborating with Mayo Clinic to integrate the HOUSES index into our platform, we aim to equip cancer centers with the clinical and social intelligence needed to deliver truly personalized, equitable care that recognizes the whole person, rather than just their condition.”
Native Epic Integration: Eliminating Administrative Friction
The commercial differentiator driving Hurone AI’s market momentum is its absolute focus on seamless clinical workflow design. Independent medical oncology groups and academic health networks are battling severe clinical staffing shortages, making them highly resistant to adopting detached software solutions that create more documentation drag than they eliminate. Hurone counters this by delivering a highly integrated architecture that integrates natively into the Epic EHR.
Because the platform writes directly back to native clinical views, oncology teams do not need to log into an external portal or toggle away from their active chart to review social risk markers. The system interprets patient signals, manages complex administrative tasks in the background, and seamlessly escalates care to live clinical teams the moment a severe symptomatic or social boundary is crossed.
Currently deployed across prominent academic medical centers to manage thousands of active cases, Hurone’s scalable data architecture provides a clear path to resolve health disparities while simultaneously lowering the administrative workload burdening oncology teams.
